<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":3072,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
Edwards Lifesciences AG v. CoreValve, Inc., 699 F.3d 1305, 105 U.S.P.Q.2d 1039 (Fed. Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/7c89eb65b811b8e253f791580b182d4a'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/7c89eb65b811b8e253f791580b182d4a'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1IVJKC003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1IVJKC003">Previous Result: <span>Hylton v. Anytime Towing, CASE NO. 11cv1...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1ISD14003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1ISD14003">Next Result: <span>Reid v. Doe Run Resources Corp., 701 F.3...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation distinguished" title="Distinguished"></div>
<div class='title left' title='Edwards Lifesciences AG v. CoreValve, Inc., 699 F.3d 1305, 105 U.S.P.Q.2d 1039 (Fed. Cir. 2012), Court Opinion'>
Edwards Lifesciences AG v. CoreValve, Inc., 699 F.3d 1305, 105 U.S.P.Q.2d 1039 (Fed. Cir....
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>Edwards Lifesciences AG v. CoreValve, Inc., 699 F.3d 1305, 105 U.S.P.Q.2d 1039 (Fed. Cir. 2012), Court Opinion</div>
<div class='docId'>X1EGNU0N</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>Edwards Lifesciences AG v. CoreValve, Inc.</div>
<div class='displayCitation'>105 U.S.P.Q.2d 1039</div>
<div class='displayCitation'>2011-1215 and 2011-1257</div>
<div class='displayCitation'>2012 BL 296477</div>
<div class='displayCitation'>2012 BL 299141</div>
<div class='displayCitation'>699 F.3d 1305</div>
<div class='displayCitation'>bna a0d5g1u1e5</div>
<div class='displayCitation'>wkffecase:26679830</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1EGNU0N" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="Edwards Lifesciences AG v. CoreValve, Inc., 699 F.3d 1305, 105 U.S.P.Q.2d 1039 (Fed. Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="Edwards Lifesciences AG v. CoreValve, Inc." />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1EGNU0N?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1EGNU0N&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1EGNU0N" /><input id="title" name="title" type="hidden" value="Edwards Lifesciences AG v. CoreValve, Inc., 699 F.3d 1305, 105 U.S.P.Q.2d 1039 (Fed. Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="DISTINGUISHED" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="7c89eb65b811b8e253f791580b182d4a" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1EGNU0N" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="true" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%37c%38%39eb%36%35b%38%31%31b%38e%32%35%33f%37%39%31%35%38%30b%31%38%32d%34a%2Fdocument%2FX%31EGNU%30N%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/bcite/X1EGNU0N/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/bcite/X1EGNU0N/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/bcite/X1EGNU0N/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/related_content/X1EGNU0N?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
							function Blaw__Citator()
							{
								window.location="bloomberg:bcite_url_prefix=/rest/documents/1561065495";
							}
						</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,ReporterOfDecisions,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">699 F3d 1305</div>
<div class="cite" data-cite-type="ReporterOfDecisions">105 U.S.P.Q.2d 1039</div>
<div class="cite" data-cite-type="DocketNumber">2011-1215 and 2011-1257</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 296477</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">U.S.P.Q.2d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">***</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br><br><p><a HREF="#id390964164331">Majority Opinion</a> &gt; <a HREF="#id390966140683">Concurring Opinion</a> &gt; </p>
</div>
<br><center>U.S. Court of Appeals, Federal Circuit</center>
<br><hr width="65%">
<div align="center"><p>
 EDWARDS LIFESCIENCES AG AND EDWARDS LIFESCIENCES LLC, Plaintiffs-Cross Appellants, v. COREVALVE, INC. AND MEDTRONIC COREVALVE, LLC, Defendants-Appellants.
</p></div>
<hr width="65%">
<center>

 2011-1215 and 2011-1257

</center>
<br><center>
November 13, 2012<span CLASS="page_no" data-cite="105 uspq 2d 1040" data-cite-type="ReporterOfDecisions" data-cite-pageno="1040" data-primary-citation="105 U.S.P.Q.2d 1039">[**1040]</span> 
</center>
<div class="headnotesToggle clearfix"><button id="toggle_headnotes_button" class="bootstrap skinButton sourceButton wide right hideSource" data-target="#headnotes_container"><span>Hide Headnotes</span></button></div>
<div class="headnotesContainer" id="headnotes_container">
<div class="headnotesContainerTitle">BNA Headnotes</div>
<div class="headnoteTitle"><a href="http://www.bloomberglaw.com/document/1475619602000128">U.S. Patents Quarterly</a></div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">PATENTS</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_931494" href="#headnote_ref_pq2-dec_931494">[1]</a> <span>Patentability/Validity &mdash; Specification &mdash; Enablement </span> <a href="http://www.bloomberglaw.com/document/1561065495/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=115.1105" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="115.1105">&#9658;115.1105</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_1" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_1" class="headnoteContent"></div>
<div class="headnote_text">
Substantial evidence supports jury's finding that patent for prosthetic heart valve inserted by balloon catheter is not invalid for lack of enablement, even though stent/valve prosthesis had been implanted only in pigs at time application was filed, since federal district court correctly instructed jury that some routine amount of experimentation to make and use claimed invention is allowable, since enablement requirement may be met by animal tests or in vitro data if experimentation on human subjects is inappropriate, as in testing and development of drugs and medical devices, since jury heard evidence that prosthesis was successfully implanted in pigs in accordance with patent's specification, and that pigs were standard experimental animal for heart valve research, and since witnesses for both sides discussed vascular anatomies of pigs, use of porcine valves in humans, and nature of ongoing experimentation, in light of district court&rsquo;s instruction.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_931495" href="#headnote_ref_pq2-dec_931495">[2]</a> <span>Infringement &mdash; Construction of claims </span> <a href="http://www.bloomberglaw.com/document/1561065495/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.03" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.03">&#9658;120.03</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_2" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_2" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Infringement &mdash; Literal infringement </span> <a href="http://www.bloomberglaw.com/document/1561065495/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.05" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.05">&#9658;120.05</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_3" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_3" class="headnoteContent"></div>
<div class="headnote_text">
Substantial evidence supports jury's finding that accused device meets &ldquo;cylindrical support means&rdquo; limitation of claim directed to prosthetic heart valve inserted by balloon catheter, since federal district court correctly determined that claims do not require support means to have diameter that is &ldquo;constant along a longitudinal axis,&rdquo; since, applying this construction, infringement plaintiffs' expert testified that portion of accused prosthesis that supports valve is cylindrical, and that accused device is &ldquo;cylindrical support means which is radially collapsible for introduction within the body channel,&rdquo; since plaintiffs presented evidence that specification describes device designed for &ldquo;implantation in a body channel,&rdquo; and that anatomical channels are rarely perfect cylinders, and since witnesses for both sides agreed that accused prosthesis is shaped to fit at conjunction of aorta and left ventricle in order to inhibit migration of stent after implantation.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_931496" href="#headnote_ref_pq2-dec_931496">[3]</a> <span>Infringement &mdash; Construction of claims </span> <a href="http://www.bloomberglaw.com/document/1561065495/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.03" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.03">&#9658;120.03</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_4" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_4" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Infringement &mdash; Literal infringement </span> <a href="http://www.bloomberglaw.com/document/1561065495/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=120.05" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="120.05">&#9658;120.05</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_5" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_5" class="headnoteContent"></div>
<div class="headnote_text">
Substantial evidence supports jury's finding that accused device meets limitation, in claim directed to prosthetic heart valve inserted by balloon catheter, that requires &ldquo;commisural supports&rdquo;
projecting in &ldquo;a direction generally parallel&rdquo; to longitudinal axis of &ldquo;cylindrical support means&rdquo; of stent, since both parties presented testimony and argument at trial that was in direct conflict on this issue, and jury could have believed plaintiffs' experts, and not defendants' experts, as to manner in which accused devices were structured and operated.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">REMEDIES</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_931497" href="#headnote_ref_pq2-dec_931497">[4]</a> <span>Monetary &mdash; Damages &mdash; Patents &mdash; Lost profits </span> <a href="http://www.bloomberglaw.com/document/1561065495/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=510.0507.05" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="510.0507.05">&#9658;510.0507.05</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_6" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_6" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Monetary &mdash; Damages &mdash; Patents &mdash; Increased damages </span> <a href="http://www.bloomberglaw.com/document/1561065495/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=510.0507.07" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="510.0507.07">&#9658;510.0507.07</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_7" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_7" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Monetary &mdash; Attorneys' fees; costs &mdash; Patents &mdash;
Exceptional case </span> <a href="http://www.bloomberglaw.com/document/1561065495/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=510.0905.03" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="510.0905.03">&#9658;510.0905.03</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_8" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_8" class="headnoteContent"></div>
<div class="headnote_text">
Jury's award of lost profits is affirmed, despite defendants' contention that they could have avoided infringement by manufacturing accused device overseas, since, whether or not defendants could have avoided infringement, they did not do so, and record shows that defendants were familiar with patent in suit and its inventors; federal district court's denial of enhanced damages and attorneys' fees is also affirmed, even though district court sustained jury's finding of willful infringement, since court did not abuse its discretion in finding that issues were &ldquo;sufficiently close,&rdquo; and that defenses were not frivolous.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_931498" href="#headnote_ref_pq2-dec_931498">[5]</a> <span>Non-monetary and injunctive &mdash; Equitable relief &mdash;
Permanent injunctions &mdash; Patents </span> <a href="http://www.bloomberglaw.com/document/1561065495/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=505.0709.07" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="505.0709.07">&#9658;505.0709.07</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_9" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_9" class="headnoteContent"></div>
<div class="headnote_text">
Absent adverse equitable considerations, winner of judgment of patent validity and infringement may normally expect to regain market exclusivity that was lost with infringement; in present case, in which jury returned verdict of infringement of patent for prosthetic heart valve inserted by balloon catheter, denial of permanent injunction is vacated and remanded for consideration in light of ensuing events and any other relevant factors, since plaintiffs practice their invention and are direct competitors in market, since, at time injunction was denied, sales in United States had not yet been authorized by U.S. Food and Drug Administration, as to either patented or infringing products, and plaintiffs thus had not lost their first-mover advantage, market share, or reputation, and since defendants represented to federal district court that they were moving their manufacturing operation to Mexico, and that infringement would therefore terminate, but defendants have continued their infringing manufacturing operations in California.</div>
</div>
</div>
<script type="text/javascript">
					jQuery(function($) {
						$('#toggle_headnotes_button').click(document_toggleHeadnoteVisibility);
					});
				</script><p class="level" align="" style="text-indent: 0pt;">Appeal from the United States District Court for the District of Delaware in No. 08-CV-0091, Chief Judge Gregory M. Sleet.<span CLASS="page_no" data-cite="699 f 3d 1307" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1307" data-primary-citation="699 F3d 1305">[*1307]</span> </p>
<div align="left">
<br><br>

<p class="level" align="" style="text-indent: 0pt;">JOHN E. NATHAN, Paul, Weiss, Rifkind, Wharton &amp; Garrison, LLP, of New York, New York, argued for plaintiffs-cross appellants. With him on the brief were CATHERINE NYARADY, KRIPA RAMAN, BRIAN P. EGAN and ROBERT A. WEINSTOCK. <span CLASS="page_no" data-cite="105 uspq 2d 1041" data-cite-type="ReporterOfDecisions" data-cite-pageno="1041" data-primary-citation="105 U.S.P.Q.2d 1039">[**1041]</span> Of counsel on the brief was JACK B. BLUMENFELD, of Wilmington, Delaware.</p>


<p class="level" align="" style="text-indent: 0pt;">JEFFREY W. SARLES, Mayer Brown LLP, of Chicago, Illinois, argued for defendants-appellants. With him on the brief were JAMES R. FERGUSON, MELISSA A. ANYETEI and BRENT A. BATZER. Of counsel on the brief were DONALD M. FALK and RITA K. LOMIO, of Palo Alto, California.</p>

</div>
<div align="left">
<br><br>
 
<p class="level" align="" style="text-indent: 0pt;">Before RADER, Chief Judge, NEWMAN and PROST, Circuit Judges.</p>
<p class="level" align="" style="text-indent: 0pt;">Opinion for the court filed by Circuit Judge NEWMAN.</p>
<p class="level" align="" style="text-indent: 0pt;">Concurring opinion filed by Circuit Judge PROST.</p>

</div>
<br><a NAME="id390964164331"></a><div id="contentMajOp" printdualcolumn="true">
<p class="level" align="" style="text-indent: 0pt;">
 NEWMAN, Circuit Judge.
</p>
<p class="level" align="" style="text-indent: 0pt;">Edwards Lifesciences AG and Edwards Lifesciences LLC (collectively "Edwards") sued defendants CoreValve, Inc. and its successor in interest Medtronic CoreValve, LLC (collectively "CoreValve") for infringement of  United States Patent No. 5,411,552 ("the  '552 patent") issued May 2, 1995, entitled "Valve Prosthesis for Implantation in the Body and a Catheter for Implanting Such Valve Prosthesis." Two other patents, initially in suit, are not at issue. The inventors are Dr. Henning R. Andersen, an interventional cardiologist at Aarhus Medical School in Denmark, his surgical colleague Dr. John M. Hasenkam, and then medical student Lars L. Knudsen.</p>
<p class="level" align="" style="text-indent: 0pt;">The invention is a prosthetic device called a "transcatheter heart valve." The valve is mounted on a stent and implanted in the heart by catheter, thereby avoiding open heart surgery and its associated risks. Suit for infringement was brought in the United States District Court for the District of Delaware, trial was to a jury, and the verdict was that the  '552 patent is valid, that CoreValve's Generation 3 ReValving System infringed patent claim 1, and that the infringement was willful. The jury awarded damages of $72,645,555 in lost profits and $1,284,861 as a reasonable royalty.<a class="sup" HREF="#fn_1" NAME="fr_1">
<em class="superscript"><sup>1</sup></em>
</a>
</p>
<p class="level" align="" style="text-indent: 0pt;">The district court entered judgment on the verdict, but declined to enhance damages for the willful infringement. The court also declined to issue an injunction <span CLASS="page_no" data-cite="699 f 3d 1308" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1308" data-primary-citation="699 F3d 1305">[*1308]</span> against future infringement, apparently on CoreValve's representation that, if enjoined, it would move its manufacturing operations to Mexico. The court also denied Edwards' request to modify the litigation-agreed protective order and to permit Edwards' patent counsel and technical expert to participate in the ongoing reexamination proceedings of the patent in suit and related patents. Each party appeals the rulings adverse to it.</p>
<p class="level" align="" style="text-indent: 0pt;">We affirm the district court's rulings, except that we remand for reconsideration of the court's denial of an injunction in view of the representation of changed circumstances, and for reconsideration <span CLASS="page_no" data-cite="2012 bl 296477 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[***2]</span> of the court's ruling on the protective order as applied to patents not in suit, to the extent that this issue has not become moot.</p>
<br><br><h1 class="organization">I</h1>
<h1 class="organization">VALIDITY OF THE  '552 
PATENT</h1>
<p class="level" align="" style="text-indent: 0pt;">The  '552 patent is directed to a collapsible stent that carries a valve for insertion into the heart by balloon catheter. Figure 1 of the  '552 patent shows the collapsible stent with projecting apices at <em>4.</em> Figure 2 includes the elastically collapsible valve <em>6</em> held to the apices at commissural points <em>5:</em>
</p>
<p class="level" align="" style="text-indent: 0pt;">
<a href="/rest/documents/1561065495&amp;imagename=OPN90440-1.PDF" target=" _blank">(PDF)</a><span CLASS="page_no" data-cite="105 uspq 2d 1042" data-cite-type="ReporterOfDecisions" data-cite-pageno="1042" data-primary-citation="105 U.S.P.Q.2d 1039">[**1042]</span> 
</p>
<p class="level" align="" style="text-indent: 0pt;">To implant the valve, the stent and valve are compressed into a balloon catheter, and moved through a blood vessel for release at the implantation site, where the balloon expands the stent and wedges it into the desired location for the valve. The patent illustrates various placements of the valve in the heart. Figure 8 describes "a position between the coronary arteries <em>20</em> and the left ventricle of the heart <em>21:</em>"</p>
<p class="level" align="" style="text-indent: 0pt;">
<a href="/rest/documents/1561065495&amp;imagename=OPN90440-2.PDF" target=" _blank">(PDF)</a>
</p>
<p class="level" align="" style="text-indent: 0pt;">The only ground on which CoreValve challenged validity of the patent was for lack of enablement based on the undisputed fact that at the time the  '552 patent <span CLASS="page_no" data-cite="699 f 3d 1309" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1309" data-primary-citation="699 F3d 1305">[*1309]</span> application was filed the stent/valve prosthesis had been implanted only in pigs. CoreValve also pointed out that the various experimental implants in pigs were not always successful, and that design changes were made after the patent application was filed.</p>
<p class="level" align="" style="text-indent: 0pt;">Edwards agrees that more developmental work was required at the time of filing. Co-inventor Knudsen wrote, in a contemporaneous report, that "questions such as size reduction, material and design optimization, and stent valve sterilization, remain unsolved," and that "much more work had to be done before anybody ever even contemplated using this for a human." Edwards' expert witness Dr. Buller testified that at the time the patent application was filed, it was "a device to perform testing on" and "not a device to move in and treat patients." The jury was instructed on the issue of enablement as follows:

<blockquote>
<p class="level" align="" style="text-indent: 0pt;">The Patent Laws require that the patent be sufficiently detailed to enable those skilled in the art to practice the invention. The purpose of this requirement is to ensure that the public, in exchange for the patent rights given to the inventor, obtains from the inventor a full disclosure of how to make and use the invention.</p>
<p class="level" align="" style="text-indent: 0pt;">If the inventors failed to provide an enabling disclosure, the patent is invalid. However, because descriptions in patents are addressed to those skilled in the art to which the invention pertains, an applicant for a patent need not expressly set forth in his specification subject matter which is commonly understood by persons skilled in the art.</p>
<p class="level" align="" style="text-indent: 0pt;">The enablement defense does not require an intent to withhold; all that is required is a failure to teach how to practice the full scope of the claimed invention. In other words, if a person of ordinary skill in the art could not make and use the invention disclosed in the patent without undue experimentation, the patent is invalid. However, some routine amount of experimentation to make and use the invention is allowable.</p>
<p class="level" align="" style="text-indent: 0pt;">The patent need not contain a working example if the invention <span CLASS="page_no" data-cite="2012 bl 296477 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[***3]</span> is otherwise disclosed in such a manner that one skilled in the art to which the invention pertains will be able to practice it without an undue amount of experimentation.</p>
</blockquote>
</p>
<p class="level" align="" style="text-indent: 0pt;">Final Jury Instructions at 25 (April 1, 2010).</p>
<p class="level" align="" style="text-indent: 0pt;">This instruction correctly states the law. Precedent establishes that "[t]he enablement requirement is met if the description enables any mode of making and using the invention." Johns Hopkins Univ. v. CellPro, Inc., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X36GT9?jcsearch=152%20F.3d%201342&amp;summary=yes#jcite">152 F.3d 1342</a> 
, 1361 (Fed. Cir. 1998) (quoting Engel Indus., Inc. v. Lockformer Co., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X544QF?jcsearch=946%20F.2d%201528&amp;summary=yes#jcite">946 F.2d 1528</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X544QF?jcsearch=1533%20(&amp;summary=yes#jcite">1533 (</a> Fed. Cir. 1991)). <em>See also</em> Transocean Offshore Deepwater Drilling, Inc. v. Maersk Contractors USA, Inc., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1E2RA2003?jcsearch=617%20F.3d%201296&amp;summary=yes#jcite">617 F.3d 1296</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1E2RA2003?jcsearch=1307&amp;summary=yes#jcite">1307</a>  (Fed. Cir. 2010) ("the district court erroneously required Transocean to enable the most efficient commercial embodiment, rather than the claims"); Durel Corp. v. Osram Sylvania Inc., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X50VQS?jcsearch=256%20F.3d%201298&amp;summary=yes#jcite">256 F.3d 1298</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X50VQS?jcsearch=1307&amp;summary=yes#jcite">1307</a>  (Fed. Cir. 2001) ("If the disclosure enables a person of ordinary skill in the art to make a particular metal oxide coating from at least one of the suggested precursors, the enablement requirement for that oxide coating is satisfied"). Continuing development <span CLASS="page_no" data-cite="105 uspq 2d 1043" data-cite-type="ReporterOfDecisions" data-cite-pageno="1043" data-primary-citation="105 U.S.P.Q.2d 1039">[**1043]</span> is often contemplated and necessary, while early filing is often essential.</p>
<p class="level" align="" style="text-indent: 0pt;"><a id="headnote_ref_pq2-dec_931494" href="#headnote_pq2-dec_931494">[1]</a> CoreValve argues that in no event does testing in pigs enable use in humans. However, it has long been recognized that when experimentation on human subjects is inappropriate, as in the testing and development of drugs and medical devices, the enablement requirement may be met by animal tests or <em>in vitro</em> data. <em>See<span CLASS="page_no" data-cite="699 f 3d 1310" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1310" data-primary-citation="699 F3d 1305">[*1310]</span> </em> MPEP  &sect;2164.02 ("An <em>in vitro</em> or <em>in vivo</em> animal model example in the specification, in effect, constitutes a 'working example' if that example 'correlates' with a disclosed or claimed method invention."). This general rule has been elaborated in various situations, <em>e.g.,</em> In re Brana, 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X39KI7?jcsearch=51%20F.3d%201560&amp;summary=yes#jcite">51 F.3d 1560</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X39KI7?jcsearch=1566&amp;summary=yes#jcite">1566</a>  (Fed. Cir. 1995) ("one who has taught the public that a compound exhibits some desirable pharmaceutical property in a standard experimental animal has made a significant and useful contribution to the art, even though it may eventually appear that the compound is without value in the treatment in humans"); Scott v. Finney, 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X391C2?jcsearch=34%20F.3d%201058&amp;summary=yes#jcite">34 F.3d 1058</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X391C2?jcsearch=1063&amp;summary=yes#jcite">1063</a>  (Fed. Cir. 1994) ("Testing for the full safety and effectiveness of a prosthetic device is more properly left to the Food and Drug Administration. Title 35 does not demand that such human testing occur within the confines of Patent and Trademark Office proceedings.").</p>
<p class="level" align="" style="text-indent: 0pt;">Useful criteria for determination of enablement for purposes of <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/XEIVVO003?jcsearch=35%20USC%20112&amp;summary=yes#jcite">section 112</a>  are summarized in In re Wands, 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X3I6GB?jcsearch=858%20F.2d%20731&amp;summary=yes#jcite">858 F.2d 731</a> 
 (Fed. Cir. 1988). Factors to be considered in determining whether the subject matter requires undue experimentation include "(1) the quantity of experimentation necessary, (2) the amount of direction or guidance presented, (3) the presence or absence of working examples, (4) the nature of the invention, (5) the state of the prior art, (6) the relative skill of those in the art, (7) the predictability or unpredictability of the art, and (8) the breadth of the claims." <em></em><a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X3I6GB?jcsearch=858%20F.2d%20731&amp;summary=yes#jcite">Id. at 737</a> .</p>
<p class="level" align="" style="text-indent: 0pt;">There was evidence that the stent/valve prosthetic device was successfully implanted in pigs, in accordance with the procedure described in the '552 specification. It was explained that pigs were a standard experimental animal for heart valve research. Witnesses for both sides discussed the vascular anatomies of pigs and the established use of porcine valves in humans. Witnesses discussed the nature of the ongoing <span CLASS="page_no" data-cite="2012 bl 296477 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[***4]</span> experimentation, in light of the district court's instruction on the enablement requirement. We agree with the district court that substantial evidence supported the jury verdict that invalidity on the ground of non-enablement had not been proved by clear and convincing evidence. The judgment of validity is affirmed.</p>
<br><br><h1 class="organization">II</h1>
<h1 class="organization">INFRINGEMENT</h1>
<p class="level" align="" style="text-indent: 0pt;">There was evidence at trial on the origin and development of the patented device by the Danish inventors and their licensees. Witnesses described the initial professional skepticism including refusal of medical journals to publish the inventors' results; the persistence of the inventors; and the eventual recognition of their work as "most exciting" and "pioneering." The record includes praise for the inventors from the CoreValve founder and the CoreValve CEO.</p>
<p class="level" align="" style="text-indent: 0pt;">The litigation began with "claim construction," including two Markman hearings and opinions. Claim 1 of the <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X2H04252GGJ?jcsearch=usp%205411552&amp;summary=yes#jcite">'552 patent</a>  is as follows, with emphasis added to the terms that were the focus of the dispute as to infringement:

<blockquote>
<p class="level" align="" style="text-indent: 0pt;">1. A valve prosthesis for implantation in a body channel, the valve prosthesis comprising a collapsible elastical valve which is mounted on an elastical stent, the elastical valve having a plurality of commissural points, wherein the stent comprises:</p>
<p class="level" align="" style="text-indent: 0pt;">
<em>cylindrical support means</em> which is radially collapsible for introduction within the body channel and which has a plurality of circumferentially-expandable sections such that the cylindrical support means is radially expandable for being secured within the body channel; and</p>
<p class="level" align="" style="text-indent: 0pt;">
<em>a plurality of commissural supports projecting from one side of the cylindrical support means in a direction generally parallel to the longitudinal axis thereof</em> for supporting the commissural points of the collapsible <span CLASS="page_no" data-cite="699 f 3d 1311" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1311" data-primary-citation="699 F3d 1305">[*1311]</span> valve, at least one circumferentially expandable section of the cylindrical support means lying between each of the commissural supports,</p>
<p class="level" align="" style="text-indent: 0pt;">such that the collapsible valve may be collapsed and expanded together with the <span CLASS="page_no" data-cite="105 uspq 2d 1044" data-cite-type="ReporterOfDecisions" data-cite-pageno="1044" data-primary-citation="105 U.S.P.Q.2d 1039">[**1044]</span> cylindrical support means for implantation in the body channel by means of a technique of catheterization.</p>
</blockquote>
</p>
<p class="level" align="" style="text-indent: 0pt;"> '522 patent col.7 1.57-col.8 1.19.</p>
<p class="level" align="" style="text-indent: 0pt;">The district court construed "cylindrical support means" as "a portion of the stent supporting the valve that has a shape of or relating to a cylinder." The court ruled that the portion supporting the valve had to be cylindrical, but that the entire stent did not have to be of uniform cylindrical shape. The court instructed the jury as follows:

<blockquote>
<p class="level" align="" style="text-indent: 0pt;">"cylindrical support means" means "a portion of the stent supporting the valve that has a shape of or relating to a cylinder." The term "cylindrical" does not mean that the object described must be a cylinder with a diameter that is constant along its length or longitudinal axis. To put it another way, the term "cylindrical" as used in the patent in this case does not require the presence of a perfect geometric cylinder.</p>
</blockquote>
</p>
<p class="level" align="" style="text-indent: 0pt;">Final Jury Instructions at 16-17 (April 1, 2010).</p>
<p class="level" align="" style="text-indent: 0pt;">The district court instructed the jury as to the "projecting" term of the claim, as follows: "projecting <span CLASS="page_no" data-cite="2012 bl 296477 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[***5]</span> from one side of the cylindrical support means in a direction generally parallel to the longitudinal axis thereof" means "projecting from one side of the cylindrical support means in a direction generally parallel to the longitudinal axis of the cylindrical support means."</p>
<p class="level" align="" style="text-indent: 0pt;">The accused Medtronic/CoreValve Generation 3 is shown in the trial exhibit marked by Dr. Buller in conjunction with his testimony on whether this device met the claim limitations:</p>
<p class="level" align="" style="text-indent: 0pt;">
<img src="/rest/documents/1561065495&amp;imagename=OPN90440-3.PNG" alt=""><span CLASS="page_no" data-cite="699 f 3d 1312" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1312" data-primary-citation="699 F3d 1305">[*1312]</span> 
</p>
<p class="level" align="" style="text-indent: 0pt;">The jury found infringement. The parties agreed that "projecting" and "generally parallel" should be given their plain and ordinary meaning. On this appeal, CoreValve states that the district court's claim construction and thus the jury instructions were incorrect, and that <span CLASS="page_no" data-cite="105 uspq 2d 1045" data-cite-type="ReporterOfDecisions" data-cite-pageno="1045" data-primary-citation="105 U.S.P.Q.2d 1039">[**1045]</span> on the correct construction, no reasonable jury could find infringement of the claim terms "cylindrical support means" and "commissural supports projecting ... in a direction generally parallel."</p>
<p class="level" align="" style="text-indent: 0pt;">Jury instructions are reviewed for correctness as a matter of law. Claim terms are construed in accordance with their usage in the patent specification, and as elaborated in the prosecution history. Phillips v. AWH Corp., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X12HHT2003?jcsearch=415%20F.3d%201303&amp;summary=yes#jcite">415 F.3d 1303</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X12HHT2003?jcsearch=1314&amp;summary=yes#jcite">1314</a>  (Fed. Cir. 2005) (en banc).</p>
<br><br><h1 class="organization">A</h1>
<p class="level" align="" style="text-indent: 0pt;">CoreValve argues that the district court improperly instructed the jury, by construing "cylindrical support means" sufficiently broadly that it could include the stent of the Generation 3. CoreValve states that "cylindrical support means" should be defined as a "stent structure where the mesh has a diameter that is constant along a longitudinal axis." CoreValve argues that the court's construction erroneously enlarged the ordinary meaning of "cylindrical" beyond its established meaning as a geometric term, and that the drawings in the <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X2H04252GGJ?jcsearch=usp%205411552&amp;summary=yes#jcite">'552 patent</a>  show that the inventors contemplated only the simple cylindrical shape that is illustrated in Figure 1. CoreValve states that the correct definitions exclude the Generation 3 device.</p>
<p class="level" align="" style="text-indent: 0pt;"><a id="headnote_ref_pq2-dec_931495" href="#headnote_pq2-dec_931495">[2]</a> The district court explained in its Markman opinions that CoreValve's proposed construction "imports limitations that are not supported by the patent specification or the prosecution history.... Specifically, the term 'mesh' and the limitation that the diameter be 'constant along the longitudinal axis' are not found in the specification." We agree that the court's construction comports with the specification. Applying this construction, Dr. Buller testified that the portion of the Generation 3 that supports the valve is cylindrical, and that the Generation 3 device is a "cylindrical support means which is radially collapsible for introduction within the body channel." CoreValve argued to the jury that the general shape of the Generation 3 is not "cylindrical." Edwards pointed out that the specification describes a device designed for "implantation in a body channel," and that anatomical channels are rarely perfect cylinders. Witnesses for both sides agreed that the Generation 3 shape is designed to fit at the conjunction of the aorta and the left ventricle in order to inhibit migration of the stent after implantation, and Dr. Buller testified <span CLASS="page_no" data-cite="2012 bl 296477 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[***6]</span> that the lower portion of the Generation 3 is the "cylindrical support means" for the commissural supports for the valve.</p>
<p class="level" align="" style="text-indent: 0pt;">The record shows that there was substantial evidence to support a jury finding that the cylindrical support means of the claim is embodied in the Generation 3 device.</p>
<br><br><h1 class="organization">B</h1>
<p class="level" align="" style="text-indent: 0pt;">CoreValve also argued to the jury that the commissural supports in the Generation 3 are not "generally parallel" to the longitudinal axis of the stent, as required by claim 1. CoreValve argues on this appeal that "parallel" should have been strictly construed as a geometric term with no flexibility of meaning or application, citing International Rectifier Corp. v. IXYS Corp., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X6CTRS?jcsearch=361%20F.3d%201363&amp;summary=yes#jcite">361 F.3d 1363</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X6CTRS?jcsearch=1371&amp;summary=yes#jcite">1371</a>  (Fed. Cir. 2004), where the court construed "polygonal" as requiring straight edges for only a straight-edged polygon was exemplified in the specification.<span CLASS="page_no" data-cite="699 f 3d 1313" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1313" data-primary-citation="699 F3d 1305">[*1313]</span> </p>
<p class="level" align="" style="text-indent: 0pt;">The district court construed "commissural points" to mean "points or locations where the leaflets of the valve are joined," and "commissural supports" to mean "portions of the stent that support the commissural points of the valve." The parties presented testimony and argument on the embodiment of these elements in the accused prosthesis.</p>
<p class="level" align="" style="text-indent: 0pt;">Dr. Buller in his testimony acknowledged that the drawings of the <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X2H04252GGJ?jcsearch=usp%205411552&amp;summary=yes#jcite">'552 patent</a>  show the commissural supports as taller than in the Generation 3 device.<a class="sup" HREF="#fn_2" NAME="fr_2">
<em class="superscript"><sup>2</sup></em>
</a> He testified that the Generation 3 device meets the "projecting" limitation because the "whole structure, one can say, is projecting generally upwards," drawing the upward axis on the exhibit as shown <em> supra.</em> CoreValve witnesses testified that the Generation 3 commissural supports are an "integrated wire mesh" of "rounded, interconnecting diamonds" that do not protrude or jut out from the stent and that are at a 30 degree angle from the longitudinal axis, and are not "generally parallel." CoreValve stressed the advantages of its structure that anchors the device in the aorta, as compared with the shape in the <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X2H04252GGJ?jcsearch=usp%205411552&amp;summary=yes#jcite">'552 patent</a> . Edwards' witnesses disputed CoreValve's argument that the Generation 3 commissural supports do not project from the stent structure. Edwards argued <span CLASS="page_no" data-cite="105 uspq 2d 1046" data-cite-type="ReporterOfDecisions" data-cite-pageno="1046" data-primary-citation="105 U.S.P.Q.2d 1039">[**1046]</span> that "projecting" is not limited to "sticking out" or "protruding," and its witnesses testified that the CoreValve commissural supports project in a direction generally parallel to the longitudinal axis of the supporting stent.</p>
<p class="level" align="" style="text-indent: 0pt;">The district court noted that "Dr. Buller testified that the 'top' portion of CoreValve's device as shown in PTX 2136-37 contained the commissural supports (Tr. 768:21-771-2; PTX 2137) while the 'bottom' portion contained the cylindrical support means." Edwards, at *7 n.4. The court remarked that the jury could have believed Edwards' experts and not CoreValve's experts, as to the way the devices were structured and operated.</p>
<p class="level" align="" style="text-indent: 0pt;"><a id="headnote_ref_pq2-dec_931496" href="#headnote_pq2-dec_931496">[3]</a> The testimony at trial was in direct conflict. "In determining whether the evidence at trial was sufficient to sustain the verdict, the court may not weigh the evidence, determine the credibility of witnesses, or substitute its version of the facts for the jury's version." Lightning Tube, Inc. v. Witco Corp., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X352TP?jcsearch=4%20F.3d%201153&amp;summary=yes#jcite">4 F.3d 1153</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X352TP?jcsearch=1166&amp;summary=yes#jcite">1166</a>  (3d Cir. 1993) (citation omitted). <em>See</em> Perkin-Elmer Corp. v. Computervision Corp., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X4A66Q?jcsearch=732%20F.2d%20888&amp;summary=yes#jcite">732 F.2d 888</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X4A66Q?jcsearch=893&amp;summary=yes#jcite">893</a>  (Fed. Cir. 1984) (the court may not "substitute its choice for that of <span CLASS="page_no" data-cite="2012 bl 296477 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[***7]</span> the jury between conflicting elements of the evidence").</p>
<p class="level" align="" style="text-indent: 0pt;">On the entirety of the proceedings at trial, there was substantial evidence to support the jury verdict that the Generation 3 device infringes claim 1 of the <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X2H04252GGJ?jcsearch=usp%205411552&amp;summary=yes#jcite">'552 patent</a> . The judgment of infringement is affirmed.</p>
<br><br><h1 class="organization">III</h1>
<h1 class="organization">REMEDIES</h1>
<h1 class="organization">A</h1>
<p class="level" align="" style="text-indent: 0pt;">The record states that in 2004 CoreValve moved its manufacturing from France to California and hired former Edwards engineers, and that CoreValve's first implantation in humans was in 2006. The jury awarded Edwards its lost profits for the infringement, finding that Edwards could have met the demand, starting with the initiation of the Generation 3 design in January 2006. The jury also found that the infringement was willful.<span CLASS="page_no" data-cite="699 f 3d 1314" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1314" data-primary-citation="699 F3d 1305">[*1314]</span> </p>
<p class="level" align="" style="text-indent: 0pt;"><a id="headnote_ref_pq2-dec_931497" href="#headnote_pq2-dec_931497">[4]</a> CoreValve argues that the criteria for award of lost profits were not met, stating that it "could have manufactured its device overseas by March 2007," CoreValve Br. 3, and thus would have avoided all liability for infringement, by avoiding infringement. CoreValve argues that this eliminates liability for damages based on its manufacture in the United States, or that at most it should be liable for only a modest royalty. Neither the jury nor the district court was persuaded by this argument. Nor are we. Whether or not CoreValve could have avoided infringement, it did not do so, although it was notified as early as 2005 of Edwards' position, and the record showed CoreValve's familiarity with the patents and the inventors.</p>
<p class="level" align="" style="text-indent: 0pt;">We affirm the district court's ruling sustaining the jury's damages award. <em>See</em> Brooktree Corp. v. Advance Micro Devices, 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X3K0FA?jcsearch=977%20F.2d%201555&amp;summary=yes#jcite">977 F.2d 1555</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X3K0FA?jcsearch=1580&amp;summary=yes#jcite">1580</a>  (Fed. Cir. 1992) ("the jury's finding must be upheld unless the damages award is 'grossly excessive or monstrous,' clearly not supported by the evidence, or based only on speculation or guesswork"). With respect to the verdict of willful infringement, although this finding was sustained by the district court, the court declined to enhance damages or award attorney fees, stating that the issues were "sufficiently close" and the defenses not frivolous. <em>See</em> Bard Peripheral Vascular, Inc. v. W.L. Gore &amp; Assocs., Inc., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1BM6B8N?jcsearch=682%20F.3d%201003&amp;summary=yes#jcite">682 F.3d 1003</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1BM6B8N?jcsearch=1005&amp;summary=yes#jcite">1005</a>  (Fed. Cir. 2012) (enhancement of damages is not automatic). We do not discern abuse of discretion in the court's decision not to enhance damages.</p>
<br><br><h1 class="organization">B</h1>
<p class="level" align="" style="text-indent: 0pt;">Edwards requested entry of an injunction against future infringement, and cited several equitable considerations, including the importance of establishing customer relationships now that FDA approval has been obtained, and the fact that Medtronic, as a large medical device manufacture, could overwhelm the much smaller Edwards.</p>
<p class="level" align="" style="text-indent: 0pt;"><a id="headnote_ref_pq2-dec_931498" href="#headnote_pq2-dec_931498">[5]</a> A patentee's right to exclude is a fundamental tenet of patent law. Richardson v. Suzuki Motor Co., Ltd., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X3I6NF?jcsearch=868%20F.2d%201226&amp;summary=yes#jcite">868 F.2d 1226</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X3I6NF?jcsearch=1247&amp;summary=yes#jcite">1247</a>  (Fed. Cir. 1989) ("The right to exclude recognized in a patent is but the essence of the concept of property.") (quoting Connell v. Sears, Roebuck &amp; Co., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X3J3CD?jcsearch=722%20F.2d%201542&amp;summary=yes#jcite">722 F.2d 1542</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X3J3CD?jcsearch=1548&amp;summary=yes#jcite">1548</a>  (Fed. Cir. 1983)). The innovation incentive of the patent is grounded on the market exclusivity whereby the inventor profits from his invention. Absent adverse equitable considerations, the winner of a judgment of validity and infringement may normally expect to regain the <span CLASS="page_no" data-cite="105 uspq 2d 1047" data-cite-type="ReporterOfDecisions" data-cite-pageno="1047" data-primary-citation="105 U.S.P.Q.2d 1039">[**1047]</span> exclusivity that was lost with the infringement. Edwards argues that the Court's ruling in eBay Inc. v. MercExchange, L.L.C., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X151TO4003?jcsearch=547%20U.S.%20388&amp;summary=yes#jcite">547 U.S. 388</a> 
 (2006) supports its position, for the willfulness <span CLASS="page_no" data-cite="2012 bl 296477 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[***8]</span> of the infringement and other equitable aspects weigh in favor of restoration of the exclusive patent right.</p>
<p class="level" align="" style="text-indent: 0pt;">The Court in eBay did not hold that there is a presumption against exclusivity on successful infringement litigation. The Court did not cancel 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/XEJ01G003?jcsearch=35%20USC%20154&amp;summary=yes#jcite">35 U.S.C. &sect;154</a> 
, which states that "Every patent shall contain ... a grant ... of the right to exclude others from making, using, offering for sale, or selling the invention," nor did the Court overrule <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/1?citation=USCONST%20ART%20I,%20SC%208&amp;summary=yes#jcite">Article I section 8</a>  of the Constitution, which grants Congress the power to "secur[e] for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries." The Court held that equitable aspects should always be considered, stating: "We hold only that the decision whether to grant or deny injunctive relief rests within the equitable discretion of the district courts, and that such discretion must be exercised consistent with traditional principles <span CLASS="page_no" data-cite="699 f 3d 1315" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1315" data-primary-citation="699 F3d 1305">[*1315]</span> of equity, in patent disputes no less than in other cases governed by such standards." eBay, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X151TO4003?jcsearch=547%20U.S.%20388&amp;summary=yes#jcite">547 U.S. at 394</a> . Statutory and historical as well as commercial considerations impinge on every equitable determination.</p>
<p class="level" align="" style="text-indent: 0pt;">Precedent illustrates the variety of equitable considerations, and responsive equitable remedy in patent cases; for example, the grant of a royalty-bearing license instead of imposing an injunction in situations where the patentee would experience no competitive injury, as in ActiveVideo Networks, Inc. v. Verizon Communications, Inc., [<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1I51L2003?jcsearch=694%20F.3d%201312&amp;summary=yes#jcite">694 F.3D 1312</a>], U.S. App. LEXIS 18032,  at *67-68 (Fed. Cir. Aug. 24, 2012); or where there is an overriding public interest in continued provision of the infringing product, as in Bard Peripheral Vascular, Inc. v. W.L. Gore &amp; Assocs., Inc.,  No. 03-CV-0597 (D. Ariz. July 21, 2010), where the Gore vascular graft materials were not available from the successful patentee Bard. Another form of equitable response is illustrated in Broadcom Corp. v. Qualcomm Inc., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X19JASI003?jcsearch=543%20F.3d%20683&amp;summary=yes#jcite">543 F.3d 683</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X19JASI003?jcsearch=704&amp;summary=yes#jcite">704</a>  (Fed. Cir. 2008), where the court postponed the effective date of an injunction for twenty months, to relieve hardship on the infringer.</p>
<p class="level" align="" style="text-indent: 0pt;">In Advanced Cardiovascular Sys. v. Medtronic Vascular, Inc., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X19KCRA003?jcsearch=579%20F.%20Supp.%202d%20554&amp;summary=yes#jcite">579 F. Supp. 2d 554</a> 
 (D. Del. 2008), the court observed that: "Courts awarding permanent injunctions typically do so under circumstances where plaintiff practices its invention and is a direct market competitor." <em></em><a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X19KCRA003?jcsearch=579%20F.%20Supp.%202d%20554&amp;summary=yes#jcite">Id. at 558</a> . Edwards argues that these conditions here prevail. However, the district court declined to impose the requested injunction. First, the district court responded to Edwards' argument that without exclusivity it would lose first-mover advantage and market share and reputation, by stating that these had already been lost - although Edwards states that this is incorrect, for sales in the United States had not yet been authorized by the FDA, as to either the Edwards or the CoreValve/Medtronic product. The district court also stated that Edwards had given up exclusivity by licensing the <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X2H04252GGJ?jcsearch=usp%205411552&amp;summary=yes#jcite">'552 patent</a>  to another competitor. CoreValve does not dispute that the district court erred in its view of that transaction, and that no such license exists.</p>
<p class="level" align="" style="text-indent: 0pt;">The district court's explanation of why it was withholding an injunction placed significant weight on CoreValve's statements that it was immediately moving this manufacturing operation to Mexico, and thus that infringement <span CLASS="page_no" data-cite="2012 bl 296477 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[***9]</span> would terminate. Edwards at *29 ("The remaining two eBay factors do not alter the court's analysis, since the only practical effect of a permanent injunction would be that CoreValve would be forced to move its United States manufacturing operations for the accused product to Mexico."). The district court stated that if CoreValve should renew its infringing manufacture in the United States, then "[a]s it did in this case, Edwards can bring suit against CoreValve and seek damages if CoreValve continues its infringing manufacturing operations in spite of the judgment of infringement." <em> Id.</em> at *28. Edwards states on this appeal, and CoreValve does not deny, that CoreValve never stopped its infringing manufacture in California. Whether or not that representation was known to be false when made, the situation before us reflects, at least, changed circumstances.</p>
<p class="level" align="" style="text-indent: 0pt;">In TiVo Inc. v. Echostar Corp., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1FB716003?jcsearch=646%20F.3d%20869&amp;summary=yes#jcite">646 F.3d 869</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1FB716003?jcsearch=890&amp;summary=yes#jcite">890</a>  n.9 (Fed. Cir. 2011) this court <em>en banc</em> noted that "district courts are in the best position to fashion an injunction tailored to prevent or remedy infringement." Recognizing that the circumstances have not been fully explored in the record before us, we vacate the denial of the injunction, <span CLASS="page_no" data-cite="699 f 3d 1316" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1316" data-primary-citation="699 F3d 1305">[*1316]</span> <span CLASS="page_no" data-cite="105 uspq 2d 1048" data-cite-type="ReporterOfDecisions" data-cite-pageno="1048" data-primary-citation="105 U.S.P.Q.2d 1039">[**1048]</span> and remand to the district court for consideration in light of ensuing events and any other relevant factors.</p>
<br><br><h1 class="organization">IV</h1>
<h1 class="organization">PROTECTIVE ORDER</h1>
<p class="level" align="" style="text-indent: 0pt;">The parties had stipulated to a protective order with a "patent prosecution bar," which precludes all persons who had access to the opponent's confidential information produced for this trial, from "working on patent prosecution" on this subject matter. Edwards asked the district court to confirm that this restraint did not apply to patent reexamination, pointing out that Medtronic had filed several reexamination requests against Edwards' patents. Edwards states that confidential information is not likely to be involved, but that this restriction would deprive Edwards of the services of its patent attorneys and technical expert who know most about Edwards' patents and this technology.</p>
<p class="level" align="" style="text-indent: 0pt;">The risk of inadvertent disclosure or improper use of confidential information is balanced against the potential harm of restricting a party's right to continued representation by its counsel. In In re Deutsche Bank Trust Co. Americas, 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1DAV58003?jcsearch=605%20F.3d%201373&amp;summary=yes#jcite">605 F.3d 1373</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1DAV58003?jcsearch=1381&amp;summary=yes#jcite">1381</a>  (Fed. Cir. 2010), the court held that "a party seeking imposition of a patent prosecution bar must show that the information designated to trigger the bar, the scope of activities prohibited by the bar, the duration of the bar, and the subject matter covered by the bar reasonably reflect the risk presented by the disclosure of proprietary competitive information." The district court, denying Edwards' request for relief, stated that it "would create a high risk that confidential CoreValve/Medtronic information would be used or disclosed." Meanwhile, Edwards advises that the reexamination of the <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X2H04252GGJ?jcsearch=usp%205411552&amp;summary=yes#jcite">'552 patent</a>  has now terminated (in Edwards' favor) by Order of May 20, 2011. Edwards argues that the balance of equities weighs on the side of permitting Edwards to have the services of its experienced patent attorneys and technical expert, in connection with the ongoing <span CLASS="page_no" data-cite="2012 bl 296477 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[***10]</span> reexaminations of other patents.</p>
<p class="level" align="" style="text-indent: 0pt;">Since the <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X2H04252GGJ?jcsearch=usp%205411552&amp;summary=yes#jcite">'552 patent</a>  is no longer undergoing reexamination, if the question is not moot as to other patents, on remand the district court may reconsider its protective order.</p>
<br><br><h1 class="organization">SUMMARY</h1>
<p class="level" align="" style="text-indent: 0pt;">The judgment of the district court is affirmed, with the exception that we remand for reconsideration by the district court, in view of changed circumstances, of the court's rulings on the permanent injunction and the protective order.</p>
<p class="level" align="" style="text-indent: 0pt;">
<em>AFFIRMED IN PART, REMANDED IN PART.</em>
</p>
</div>
<br><a NAME="id390966140683"></a><div id="contentConOp" printdualcolumn="true">
<p class="level" align="" style="text-indent: 0pt;">
 PROST, Circuit Judge, concurring.</p>
<p class="level" align="" style="text-indent: 0pt;">I join this opinion in all respects except one-the majority's discussion of the permanent injunction standard. The majority opines that "[a]bsent adverse equitable considerations, the winner of a judgment of validity and infringement may normally expect to regain the exclusivity that was lost with the infringement." Majority Op. 16. To the extent that one reads this statement as creating the presumption of an injunction once the plaintiff prevails, which must be rebutted by the defendant, that is not the law.</p>
<p class="level" align="" style="text-indent: 0pt;">Nor do the selected portions of eBay cited by the majority provide support for its position. First, while I agree with the majority that in eBay the Supreme Court did not cancel 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/XEJ01G003?jcsearch=35%20USC%20154&amp;summary=yes#jcite">35 U.S.C. &sect; 154</a> 
, the majority overlooks the Court's explanation that "the creation of a right is distinct from the provision of remedies for violations of that right," such that "injunctive relief 'may' <span CLASS="page_no" data-cite="699 f 3d 1317" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1317" data-primary-citation="699 F3d 1305">[*1317]</span> issue only 'in accordance with the principles of equity.'" eBay Inc. v. MercExchange, L.L.C., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X151TO4003?jcsearch=547%20U.S.%20388&amp;summary=yes#jcite">547 U.S. 388</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X151TO4003?jcsearch=392&amp;summary=yes#jcite">392</a>  (2006) (quoting 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/XEJ052003?jcsearch=35%20USC%20283&amp;summary=yes#jcite">35 U.S.C. &sect; 283</a> 
). Second, the majority excludes from its analysis the four-factor equitable standard, the preamble of which states that "the plaintiff must demonstrate" these factors. Indeed, the majority's analysis might be read to suggest that the defendant, not the plaintiff, bears the burden of establishing the equitable factors.</p>
<p class="level" align="" style="text-indent: 0pt;">Some complain of areas of patent law in which our guidance is mixed or muddled. This is not-or should not be-one of those areas after the Supreme Court's clear pronouncement in eBay. eBay made clear that there is no general rule that a successful plaintiff is entitled to an injunction; rather, the plaintiff bears the burden of establishing the four equitable factors that weigh in its favor in order to obtain a permanent injunction. We should take care to avoid possible misinterpretation of an otherwise clear Supreme Court standard. Because <span CLASS="page_no" data-cite="105 uspq 2d 1049" data-cite-type="ReporterOfDecisions" data-cite-pageno="1049" data-primary-citation="105 U.S.P.Q.2d 1039">[**1049]</span> the majority's statements appear to me to deviate from the standard articulated by the Supreme Court and our court, I respectfully concur. <em>See</em> Robert Bosch LLC v. Pylon Mfg. Corp., 
<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1GILCK003?jcsearch=659%20F.3d%201142&amp;summary=yes#jcite">659 F.3d 1142</a> 
, <a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1GILCK003?jcsearch=1149&amp;summary=yes#jcite">1149</a>  (Fed. Cir. 2011) (recognizing that "eBay abolishes our general rule that an injunction normally will issue when a patent is found to have been valid and infringed").</p>
</div>
<hr width="65%">
<table><tbody><tr align="left" valign="top">
<td align="left" valign="top"><a name="fn_1" HREF="#fr_1" class="sup1">fn</a></td>
<td align="left" valign="top"><small>1<p class="level" align="" style="text-indent: 0pt;">
Edwards Lifesciences AG v. Medtronic, Inc.,  No. 09-873-GMS, [<a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1Q6LHD00EO2?jcsearch=2011%20BL%2031282&amp;summary=yes#jcite">2011 BL 31282</a>], 2011 U.S. Dist. LEXIS 12022  (D. Del. Feb. 7, 2011).</p></small></td>
</tr></tbody></table>
<table><tbody><tr align="left" valign="top">
<td align="left" valign="top"><a name="fn_2" HREF="#fr_2" class="sup1">fn</a></td>
<td align="left" valign="top"><small>2<p class="level" align="" style="text-indent: 0pt;">It was undisputed that the two small loops at the top of the Generation 3 device are not the commissural supports; they serve to attach the stent to the catheter.</p></small></td>
</tr></tbody></table>

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1EGNU0N/history">Direct History (3)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1EGNU0N/analysis">Case Analysis (11)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1EGNU0N/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
10
</span>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/distinguished.png'>
<div class='citation distinguished icon printHide' title='Distinguished'></div>
<a class='citationAnalysisLabel' href='/bcite/X1EGNU0N/analysis?analysis=distinguished'>
Distinguished
</a>
<span class='citationNumberLabel'>
1
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Affirmed (In Part), Case Remanded (In Part)</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Medical Devices</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1Q6LHLAC2O2">11-01215 (Fed. Cir.)</a></div><div class='facetItemLabel'><a href="/s/opinion/7c89eb65b811b8e253f791580b182d4a/document/X1Q6LIL211O2">11-01257 (Fed. Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Constitutional Law</div><div class='facetItemLabel'>Copyright Law</div><div class='facetItemLabel'>Damages &amp; Remedies</div><div class='facetItemLabel'>Patent Law</div><div class='facetItemLabel'>Trademark Law</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/7c89eb65b811b8e253f791580b182d4a/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "7c89eb65b811b8e253f791580b182d4a";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY9e0765&previousPageId=&previousActivityInstanceId=ENTITY87d7ab&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:30:22-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1EGNU0N&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY87d7ab&previousPageId=&previousActivityInstanceId=ENTITY3f0f00&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:30:20-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1EGNU0N';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1EGNU0N";
$('#page_loader').show().spin();
JUDGE_IDS=["1850676","4063892"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
